(VIANEWS) – Shares of Merrimack Pharmaceuticals (NASDAQ: MACK) slid by a staggering 27.27% in 30 days from $5.83 to $4.24 at 11:17 EST on Wednesday, after two successive sessions in a row of losses. NASDAQ is rising 2.2% to $12,769.24, after three consecutive sessions in a row of losses.
Merrimack Pharmaceuticals’s last close was $4.16, 43.93% under its 52-week high of $7.41.
Today’s last reported volume for Merrimack Pharmaceuticals is 4374 which is 84.15% below its average volume of 27609.
Merrimack Pharmaceuticals’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.63%, a negative 1.90%, and a positive 3.26%, respectively.
Merrimack Pharmaceuticals’s highest amplitude of average volatility was 1.56% (last week), 2.91% (last month), and 3.26% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Merrimack Pharmaceuticals’s stock is considered to be overbought (>=80).
Merrimack Pharmaceuticals’s Stock Yearly Top and Bottom Value
Merrimack Pharmaceuticals’s stock is valued at $4.24 at 11:17 EST, way under its 52-week high of $7.41 and way above its 52-week low of $3.66.
Merrimack Pharmaceuticals’s Moving Average
Merrimack Pharmaceuticals’s value is way below its 50-day moving average of $5.53 and way below its 200-day moving average of $5.26.
More news about Merrimack Pharmaceuticals (MACK).